Rare Cancers: Targeted Drug Study

We are exploring how well existing targeted cancer drugs work for patients with rare and hard-to-treat cancers. The study will also look at any serious side effects from these treatments.

>2 years 6-10 visits Efficacy phase (II)Post-Trial Drug Access No Placebo Investigational Medicines Oral InjectionOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Finlee

Imatinib

Imatinib is a cancer medicine used to treat certain blood cancers and tumor types by blocking cancer cell growth.

Spexotras

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Dabrafenib

Dabrafenib is a substance that targets a specific gene mutation to treat certain cancers, especially melanoma.

Imatinib

Imatinib is a substance that blocks signals cancer cells need to grow, used for chronic myeloid leukemia and some gastrointestinal tumors.

Tislelizumab

Tislelizumab is a cancer immunotherapy substance that helps the immune system attack tumor cells by blocking a protein called PD-1 that restrains immune responses.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Mekinist

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Bimatix

Glipox

Glivec

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Helse Bergen HF

Oncology

Bergen, Norway

Nordlandssykehuset HF

Oncology

Bodø, Norway

Sykehuset Innlandet HF

Oncology

Brumunddal, Norway

Sponsor: Oslo University Hospital HF

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.